Mycophenolate Mofetil 2x 1g
ApprovedCompleted 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Corneal Transplantation
Conditions
Corneal Transplantation
Trial Timeline
— → —
NCT ID
NCT00411515About Mycophenolate Mofetil 2x 1g
Mycophenolate Mofetil 2x 1g is a approved stage product being developed by Roche for Corneal Transplantation. The current trial status is completed. This product is registered under clinical trial identifier NCT00411515. Target conditions include Corneal Transplantation.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00411515 | Approved | Completed |
Competing Products
12 competing products in Corneal Transplantation